Cargando…

COVID-19 associated with concomitant mucormycosis and aspergillosis

Detalles Bibliográficos
Autores principales:	Lai, Chih-Cheng, Wu, Chi-Jung, Lee, Yi-Chien, Liu, Wei-Lun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450135/ https://www.ncbi.nlm.nih.gov/pubmed/34563471 http://dx.doi.org/10.1016/j.jmii.2021.09.001

Ejemplares similares

CONCOMITANT PULMONARY MUCORMYCOSIS AND PULMONARY ASPERGILLOSIS IN A YOUNG PATIENT WITH COVID-19
por: FELDMAN, ERICA, et al.
Publicado: (2021)

COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
por: Huang, Shiang-Fen, et al.
Publicado: (2023)

Pulmonary aspergillosis, mucormycosis, and actinomycosis co-infection presenting as a cavitary lesion in a patient with diabetes
por: Lin, Lan, et al.
Publicado: (2019)

COVID-19–associated Pulmonary Aspergillosis
por: van Arkel, Andreas L. E., et al.
Publicado: (2020)

A mysterious surge of aspergillosis among non-SARS-CoV-2 patients during COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Surveillance for COVID-19-associated pulmonary aspergillosis
por: Brown, Li-An K, et al.
Publicado: (2020)

Concomitant orbital aspergillosis and mucormycosis in a 17 months old immunocompetent child
por: Habroosh, Fatima A., et al.
Publicado: (2017)

COVID-19 associated mucormycosis – An emerging threat
por: Chao, Chien-Ming, et al.
Publicado: (2022)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
por: Jabeen, Kauser, et al.
Publicado: (2021)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
por: Permpalung, Nitipong, et al.
Publicado: (2021)

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
por: Johnson, Andre K., et al.
Publicado: (2021)

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Koehler, Philipp, et al.
Publicado: (2021)

The association between immunosuppressant and the outcome of COVID-19
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
por: Ghosh, Asmita, et al.
Publicado: (2021)

Advances against Aspergillosis and Mucormycosis
por: Stevens, David A.
Publicado: (2020)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
por: Rouzé, Anahita, et al.
Publicado: (2021)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis
por: de Brabander, Justin, et al.
Publicado: (2022)

Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis
por: Lin, Chun-Yu, et al.
Publicado: (2019)

COVID-19-associated pulmonary aspergillosis (CAPA) might be associated with increased risk for pneumopleural fistula
por: Naendrup, Jan-Hendrik, et al.
Publicado: (2023)

Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL
por: Van Biesen, Stefaan, et al.
Publicado: (2020)

Mucormycosis and aspergillosis: The deadly duo in COVID-19—a case report
por: Mohanty, Bijaya, et al.
Publicado: (2022)

Concomitant Pulmonary Aspergillosis Following Severe COVID-19
por: Munir, Ahmad, et al.
Publicado: (2023)

Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review
por: Baral, Prodip Kumar, et al.
Publicado: (2022)

Ultrasound-guided Transthoracic Needle Aspiration to Diagnose Invasive Pulmonary Aspergillosis
por: Keng, Li-Ta, et al.
Publicado: (2020)

Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis – Authors' reply
por: Gangneux, Jean-Pierre, et al.
Publicado: (2022)

A seroprevalence study of COVID-19 at a campus in southern Taiwan
por: Li, Ming-Chi, et al.
Publicado: (2021)

COVID-19 associated with pulmonary aspergillosis: A literature review
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia
por: Vučićević Boras, Vanja, et al.
Publicado: (2019)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)

Immunosuppressants/Antifungals: COVID-19 associated mucormycosis, COVID-19 associated pulmonary aspergillosis and lack of efficacy: case report
Publicado: (2022)

Fungal Infection during COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
por: Fekkar, Arnaud, et al.
Publicado: (2020)

Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
por: Raut, Akshay, et al.
Publicado: (2021)

COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON
por: Casadevall, Arturo, et al.
Publicado: (2022)

Successful treatment of cutaneous mucormycosis disseminated from pulmonary mucormycosis with liposomal amphotericin B and posaconazole
por: Ding, Xiao-Lan, et al.
Publicado: (2020)

Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
por: Hu, Zhi-min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gri2l2k2uf7ei8jn0cj506v011